Pharma Focus Asia

Introduction to EU Regulatory Affairs

Authors: 

Dr James Parsley 
Head of CMC & Principal Consultant

Ellen Wilkinson 
Senior Consultant

Introduction

In the European Union (EU) a network of approximately 50 regulatory authorities from the 30 European Economic Area (EEA) countries1, the European Commission (EC) and European Medicines Agency (EMA)  form  the basis of the European regulatory system and play a role in the  authorisation and monitoring of medicines in this region. The continuously developing regulatory landscape and regular updates to guidance poses a particular challenge to drug developers when considering the path to marketing authorisation (MA) in the EU and which route will be most efficient and cost effective whilst still complying with regulatory guidance.

When initiating development of a new medicinal product Sponsors should first draw up a drug development strategy that considers the legal basis for approval, the product type, indication, target population, key applicable guidance and when interactions with Regulators will prove most useful. Drug development strategies will continue to evolve as more data becomes available throughout development.

In this article we provide an overview of EU regulatory affairs to help guide Developers with key decisions regarding their drug development strategy. Specifically, we explore EU product classifications, the EU legal basis for MA, considerations for designations that expedite/ provide financial incentives for development and unlock early interaction with EU Regulators plus points of interaction with the EMA and National Authorities and when these are most useful during drug development. Additionally, we provide insight on considerations for clinical trial applications (CTAs) and highlight the MA Application (MAA) registration pathways available with the EMA.

For more information, please visit the website at www.Scendea.com and contact email at [email protected].

https://www.scendea.com/articles/introduction-to-eu-regulatory-affairs?utm_source=Ne[…]ium=Link&utm_campaign=PharmaFocusEUReg&utm_id=PharmaFocusAsia

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference